chr7-99849658-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_057095.3(CYP3A43):āc.634A>Cā(p.Lys212Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000059 in 1,610,116 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_057095.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYP3A43 | NM_057095.3 | c.634A>C | p.Lys212Gln | missense_variant | 7/13 | ENST00000354829.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYP3A43 | ENST00000354829.7 | c.634A>C | p.Lys212Gln | missense_variant | 7/13 | 1 | NM_057095.3 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152066Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000105 AC: 26AN: 247576Hom.: 0 AF XY: 0.0000897 AC XY: 12AN XY: 133784
GnomAD4 exome AF: 0.0000590 AC: 86AN: 1458050Hom.: 0 Cov.: 31 AF XY: 0.0000579 AC XY: 42AN XY: 725286
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152066Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74262
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2023 | The c.634A>C (p.K212Q) alteration is located in exon 7 (coding exon 7) of the CYP3A43 gene. This alteration results from a A to C substitution at nucleotide position 634, causing the lysine (K) at amino acid position 212 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at